Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of Aciclovir Prophylaxis of Herpes Infections in Critical Care
2006-000612-24Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aciclovir in herpes simplex (HSV), sponsored by NHS Greater Glasgow and Clyde. Primary endpoints: Change in Karnofsky performance status at day 28 and Change in Karnofsky performance status at day 90. Started Feb 2006; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on 2006-000612-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000612-24.